The University of Chicago Header Logo

Connection

Valluvan Jeevanandam to Tissue Donors

This is a "connection" page, showing publications Valluvan Jeevanandam has written about Tissue Donors.
Connection Strength

1.582
  1. A one-year comparison of prophylactic donor tricuspid annuloplasty in heart transplantation. Ann Thorac Surg. 2004 Sep; 78(3):759-66; discussion 759-66.
    View in: PubMed
    Score: 0.200
  2. Commentary: Warm ischemic injury to human donor hearts-when is it too much? J Thorac Cardiovasc Surg. 2024 Apr; 167(4):1361-1362.
    View in: PubMed
    Score: 0.188
  3. Improving the metrics for donor heart sizing. J Card Surg. 2021 Sep; 36(9):3250.
    View in: PubMed
    Score: 0.160
  4. Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States. Am J Transplant. 2017 Oct; 17(10):2559-2566.
    View in: PubMed
    Score: 0.121
  5. Accepting Hearts From Hepatitis C-Positive Donor: Can We Expand the Donor Pool? J Card Fail. 2017 Oct; 23(10):762-764.
    View in: PubMed
    Score: 0.121
  6. Standard criteria for an acceptable donor heart are restricting heart transplantation. Ann Thorac Surg. 1996 Nov; 62(5):1268-75.
    View in: PubMed
    Score: 0.116
  7. Adult orthotopic heart transplantation using undersized pediatric donor hearts. Technique and postoperative management. Circulation. 1994 Nov; 90(5 Pt 2):II74-7.
    View in: PubMed
    Score: 0.101
  8. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant. 1994 Jul-Aug; 13(4):681-7; discussion 685-7.
    View in: PubMed
    Score: 0.099
  9. Use of triiodothyronine replacement therapy to reverse donor myocardial dysfunction: creating a larger donor pool. Transplant Proc. 1993 Dec; 25(6):3305-6.
    View in: PubMed
    Score: 0.095
  10. Who is the high-risk recipient? Predicting mortality after heart transplant using pretransplant donor and recipient risk factors. Ann Thorac Surg. 2011 Aug; 92(2):520-7; discussion 527.
    View in: PubMed
    Score: 0.080
  11. Donor tricuspid annuloplasty during orthotopic heart transplantation: long-term results of a prospective controlled study. Ann Thorac Surg. 2006 Dec; 82(6):2089-95; discussion 2095.
    View in: PubMed
    Score: 0.058
  12. Impact of prophylactic donor heart tricuspid valve annuloplasty on outcomes in heart transplantation. J Cardiothorac Surg. 2023 Oct 12; 18(1):288.
    View in: PubMed
    Score: 0.047
  13. The American Association for Thoracic Surgery 2023 Expert Consensus Document: Adult cardiac transplantation utilizing donors after circulatory death. J Thorac Cardiovasc Surg. 2023 09; 166(3):856-869.e5.
    View in: PubMed
    Score: 0.046
  14. Simultaneous Heart-Liver Transplantation for Congenital Heart Disease in the United States: Rapidly Increasing With Acceptable Outcomes. Hepatology. 2021 04; 73(4):1464-1477.
    View in: PubMed
    Score: 0.039
  15. The role of gender in heart transplantation. Ann Thorac Surg. 1998 Jan; 65(1):88-94.
    View in: PubMed
    Score: 0.031
  16. Triiodothyronine: spectrum of use in heart transplantation. Thyroid. 1997 Feb; 7(1):139-45.
    View in: PubMed
    Score: 0.030
  17. Functional and morphologic adaptation of undersized donor hearts after heart transplantation. J Am Coll Cardiol. 1995 Sep; 26(3):737-42.
    View in: PubMed
    Score: 0.027
  18. Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction. J Heart Lung Transplant. 2010 Mar; 29(3):346-51.
    View in: PubMed
    Score: 0.018
  19. Radiofrequency ablation of Wolff-Parkinson-White syndrome in a donor heart after orthotopic heart transplantation. J Heart Lung Transplant. 1994 Sep-Oct; 13(5):905-9.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.